Conflict of Interest:
Conflicts of Interest are as follows; the remaining co-authors do not
have any conflicts of interest.
Bruce Korf:
- Chair, Children’s Tumor Foundation Medical Advisory Committee
- Chair, External Advisory Committee for NTAP and also for NF Research
Initiative
- Member, advisory committees for AstraZeneca and Springworks
Robert Kesterson is a lead advisor for
Infixion
David Bedwell is consultant for
PTC Therapeutics, Inc.
Deeann Wallis, Robert Kesterson, and Bruce Korf are inventors on US
Provisional Patent Application No. 62/903,521 - Exon skipping to treat
Neurofibromatosis Type 1.
Data Sharing: Data Availability Statement: Data available on
request from the authors.